Taken together, above results indicated that PLOD3 exerted its drug-resistance promoting capacity via inducing FoxO3 protein degradation, which resulted in abundant Survivin expression, and led to Trastuzumab resistance formation in GC cells. This evidence concerns the gene BIRC5 and gastric cancer.